Fraunhofer and grit42 join forces in the global fight against antimicrobial resistance

After a successful collaboration around the New Drugs for Bad Bugs (ND4BB) TRANSLOCATION project, funded by the Innovative Medicines Initiative (IMI), once again Fraunhofer IME and grit42 are working together under the global umbrella of IMI’s AMR Accelerator. The combined efforts of Fraunhofer IME and grit42 is to facilitate a coherent and annotated data structure for the new IMI-backed project, Gram-Negative Antibacterials NOW (GNA NOW), which also focuses on AntiMicrobial Resistance (AMR).